KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Inventory Average (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 15 years of Inventory Average data on record, last reported at $450.0 million in Q4 2025.

  • For Q4 2025, Inventory Average fell 11.74% year-over-year to $450.0 million; the TTM value through Dec 2025 reached $450.0 million, down 11.74%, while the annual FY2025 figure was $448.7 million, 16.71% down from the prior year.
  • Inventory Average reached $450.0 million in Q4 2025 per JAZZ's latest filing, down from $494.0 million in the prior quarter.
  • Across five years, Inventory Average topped out at $1.2 billion in Q3 2021 and bottomed at $105.4 million in Q1 2021.
  • Average Inventory Average over 5 years is $664.2 million, with a median of $619.5 million recorded in 2023.
  • Peak YoY movement for Inventory Average: surged 1198.87% in 2021, then crashed 34.76% in 2022.
  • A 5-year view of Inventory Average shows it stood at $1.1 billion in 2021, then plummeted by 34.76% to $721.1 million in 2022, then fell by 16.18% to $604.4 million in 2023, then fell by 15.64% to $509.9 million in 2024, then fell by 11.74% to $450.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $450.0 million in Q4 2025, $494.0 million in Q3 2025, and $498.9 million in Q2 2025.